Home » Topics » BioWorld Science

BioWorld Science
RSS

Japanese researchers present IDO1 and/or TDO inhibitors

May 8, 2019

Merck & Co. patents LRKK2-mutant inhibitors

May 8, 2019

Pilot study of L1-79 demonstrates trends towards improvement in male subjects with ASD

May 8, 2019

First-in-human data presented for IVMED-10 and IVMED-20 for post-cataract inflammation

May 8, 2019

Ocular Therapeutix presents preliminary first-in-human data for OTX-TIC implant

May 8, 2019

Dupixent receives European approval for severe asthma

May 8, 2019

Lentiviral CYBB gene therapy relieves disease symptoms in an X-CGD infant

May 8, 2019

FDA clears IND application for NNI-362

May 8, 2019

Humanized cells allow efficient flu virus isolation and growth

May 8, 2019

Waylivra receives conditional marketing authorization from the European Commission

May 8, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...